skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
A global symposium pays attention to Nav 1.7 Chronic Pain Treatment, DWP17061.
Date 2019-06-25 Hit 2532
News List
Prev Daewoong Pharmaceutical’s ‘Nabota’ secured application to blepharospasm.
Next DWN12088, Daewoong Pharmaceutical’s new drug for pulmonary fibrosis, enters global clinical studies phase 1.